655002073	655002073	CD	B-NP	O
|	|	NN	I-NP	O
DGMC	DGMC	NN	I-NP	O
|	|	NN	I-NP	O
29066151	29066151	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
513959	513959	CD	B-NP	O
|	|	CC	I-NP	O
10/28/2000	10/28/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/2/2000	11/2/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/24/2000	10/24/2000	CD	B-NP	O
SERVICE	SERVICE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
service	service	NN	I-NP	O
on	on	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
care	care	NN	B-NP	O
was	be	VBD	B-VP	O
Cardiology	Cardiology	NNP	B-NP	O
Broketroit	Broketroit	NNP	I-NP	O
Ma	Ma	NNP	I-NP	O
Ri	Ri	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
Mrs.	Mrs.	NNP	B-NP	O
Wetterauer	Wetterauer	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54-year-old	54-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
;	;	:	O	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Crotamp	Crotamp	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
severe	severe	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
on	on	IN	B-PP	O
7/10	7/10	CD	B-NP	O
The	The	DT	B-NP	O
summary	summary	NN	I-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
events	event	NNS	I-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
7/11	7/11	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
intercourse	intercourse	NN	B-NP	O
and	and	CC	O	O
``	``	``	O	O
collapsed	collapse	VBD	B-VP	O
.	.	.	O	O
''	''	''	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
and	and	CC	O	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
paramedics	paramedic	NNS	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
attempted	attempt	VBD	B-VP	O
to	to	TO	I-VP	O
intubate	intubate	VB	I-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
field	field	NN	I-NP	O
and	and	CC	O	O
found	find	VBD	B-VP	O
her	her	PRP$	B-NP	O
pulse	pulse	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
about	about	RB	B-NP	O
60	60	CD	I-NP	O
percent	percent	NN	I-NP	O
on	on	IN	B-PP	O
bag	bag	NN	B-NP	O
valve	valve	NN	I-NP	O
mask	mask	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
so	so	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
described	describe	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
episode	episode	NN	I-NP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
as	as	IN	B-SBAR	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
``	``	``	O	O
gurgling	gurgle	VBG	B-VP	O
.	.	.	O	O
''	''	''	O	O

She	She	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
describe	describe	VB	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
took	take	VBD	B-VP	O
her	her	PRP$	B-NP	O
inhalers	inhaler	NNS	I-NP	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
help	help	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
cough	cough	VB	I-VP	O
quite	quite	RB	B-NP	O
a	a	DT	I-NP	O
bit	bit	NN	I-NP	O
and	and	CC	O	O
coughed	cough	VBD	B-VP	O
up	up	RP	B-PRT	O
some	some	DT	B-NP	O
frothy	frothy	JJ	I-NP	O
white	white	JJ	I-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
immediately	immediately	RB	I-VP	O
intubated	intubate	VBN	I-VP	O
at	at	IN	B-PP	O
Sirose	Sirose	NNP	B-NP	O
There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
difficulty	difficulty	NN	I-NP	O
intubating	intubate	VBG	B-VP	O
her	her	PRP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ultimately	ultimately	RB	I-VP	O
intubated	intubate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
anesthesiologist	anesthesiologist	NN	I-NP	O
there	there	RB	B-ADVP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
percent	percent	NN	I-NP	O
with	with	IN	B-PP	O
flat	flat	JJ	B-NP	B-protein
CKs	CK	NNS	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
six	six	CD	B-NP	O
liters	liter	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
BUN	BUN	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
10/11	10/11	CD	B-NP	O
A	A	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
there	there	EX	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
40/15	40/15	CD	B-NP	O
,	,	,	O	O
wedge	wedge	NN	B-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
of	of	IN	B-PP	O
5.2	5.2	CD	B-NP	O
.	.	.	O	O

Hemodymanics	Hemodymanic	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
at	at	IN	B-PP	O
Chebanks	Chebanks	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
indicate	indicate	VBP	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
was	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
SVR	SVR	NN	I-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
index	index	NN	I-NP	O
fell	fall	VBD	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
two	two	CD	I-NP	O
's	's	POS	B-NP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
SVR	SVR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1340	1340	CD	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
jumped	jump	VBD	B-VP	O
up	up	RP	B-PRT	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
three	three	CD	I-NP	O
's	's	POS	B-NP	O
at	at	IN	B-PP	O
about	about	RB	B-NP	O
3.8	3.8	CD	I-NP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
SVR	SVR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
much	much	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
down	down	IN	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
800s	800	NNS	I-NP	B-DNA
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
gentamicin	gentamicin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
times	time	NNS	I-NP	O
one	one	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
clindamycin	clindamycin	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
caused	cause	VBN	I-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
dose	dose	NN	I-NP	O
there	there	RB	B-ADVP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Solu-Medrol	Solu-Medrol	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
intravenous	intravenous	JJ	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	B-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Misutch	Misutch	NNP	I-NP	O
University	University	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
2/7	2/7	CD	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ceter	Ceter	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
atypical	atypical	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
nondiagnostic	nondiagnostic	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
6	6	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
19	19	CD	B-NP	O
seconds	second	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
94	94	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
then	then	RB	B-ADVP	O
was	be	VBD	B-VP	O
ultimately	ultimately	RB	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
cause	cause	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
on	on	IN	B-PP	O
4/27	4/27	CD	B-NP	O
She	She	NNP	I-NP	O
was	be	VBD	B-VP	O
last	last	JJ	B-NP	O
admitted	admit	VBN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	IN	B-PP	O
,	,	,	O	O
on	on	IN	B-PP	O
2/7	2/7	CD	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Lordchild	Lordchild	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
atypical	atypical	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
dual	dual	JJ	I-NP	O
chamber	chamber	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
in	in	IN	B-PP	O
6/19	6/19	CD	B-NP	O
Diabetes	Diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

Paroxysmal	Paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
well-controlled	well-controlled	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

Past	Past	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
has	have	VBZ	B-VP	O
revealed	reveal	VBN	I-VP	O
brief	brief	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

Negative	Negative	JJ	B-NP	O
breast	breast	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
in	in	IN	B-PP	O
3/13	3/13	CD	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
medications	medication	NNS	I-NP	O
include	include	VBP	B-VP	O
amiodarone	amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Prempro	Prempro	NNP	B-NP	O
0.625	0.625	CD	I-NP	O
/	/	SYM	B-NP	O
2.5	2.5	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
sublingual	sublingual	JJ	B-ADJP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
,	,	,	O	O
beclomethasone	beclomethasone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Ventolin	Ventolin	NN	B-NP	B-protein
.	.	.	O	O

Medications	Medication	NNS	B-NP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
Lovenox	Lovenox	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	B-protein
600	600	CD	I-NP	I-protein
intravenous	intravenous	JJ	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Zantac	Zantac	NNP	B-NP	O
,	,	,	O	O
Albuterol	Albuterol	NNP	B-NP	O
,	,	,	O	O
Flovent	Flovent	NNP	B-NP	O
,	,	,	O	O
Solu-Medrol	Solu-Medrol	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
amiodarone	amiodarone	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	B-protein
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
ten	ten	CD	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
and	and	CC	I-NP	O
quit	quit	NN	I-NP	O
in	in	IN	B-PP	O
1968	1968	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
intravenous	intravenous	JJ	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
retired	retire	VBN	I-VP	O
from	from	IN	B-PP	O
Medical	Medical	JJ	B-NP	O
Records	Record	NNS	I-NP	O
at	at	IN	B-PP	O
SGH	SGH	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
three	three	CD	B-NP	O
grown	grow	VBN	I-NP	O
children	child	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
married	marry	VBN	I-VP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Physical	Physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
114/93	114/93	CD	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
high	high	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
200s	200s	CD	I-NP	O
.	.	.	O	O

Pulse	Pulse	NN	B-NP	O
is	be	VBZ	B-VP	O
60	60	CD	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
is	be	VBZ	B-VP	O
96.5	96.5	CD	B-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
97	97	CD	B-NP	O
percent	percent	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
agitated	agitated	JJ	I-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
veins	vein	NNS	I-NP	O
were	be	VBD	B-VP	O
about	about	RB	B-NP	O
5.0	5.0	CD	I-NP	O
to	to	TO	I-NP	O
6.0	6.0	CD	I-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lung	lung	NN	I-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
base	base	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
one	one	CD	I-NP	O
clear	clear	JJ	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
split	split	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
normal	normal	JJ	B-NP	O
S2	S2	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
soft	soft	JJ	I-NP	O
S3	S3	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
intact	intact	JJ	B-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
careful	careful	JJ	B-NP	O
neurologic	neurologic	JJ	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
impossible	impossible	JJ	B-ADJP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
agitation	agitation	NN	I-NP	O
and	and	CC	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Laboratory	Laboratory	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
Troponin	Troponin	NN	I-NP	B-protein
of	of	IN	B-PP	O
0.02	0.02	CD	B-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
1.3	1.3	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
38.0	38.0	CD	B-NP	O
,	,	,	O	O
BUN/creatinine	BUN/creatinine	NN	B-NP	O
of	of	IN	B-PP	O
24/0	24/0	CD	B-NP	O
.6	.6	CD	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Mrs.	Mrs.	NNP	B-NP	O
Digerolamo	Digerolamo	NNP	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Aley	Aley	NNP	I-NP	O
Coness-o	Coness-o	NNP	I-NP	O
Meoak	Meoak	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
and	and	CC	O	O
managed	manage	VBN	B-VP	O
by	by	IN	B-PP	O
problems	problem	NNS	B-NP	O
as	as	IN	B-PP	O
follows	follow	VBZ	B-VP	O
.	.	.	O	O

Flash	Flash	NNP	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Edema	Edema	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
initial	initial	JJ	I-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
Mrs.	Mrs.	NNP	B-NP	O
Kozicki	Kozicki	NNP	I-NP	O
was	be	VBD	B-VP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
being	be	VBG	B-VP	O
an	an	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
event	event	NN	I-NP	O
causing	cause	VBG	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
clean	clean	JJ	B-NP	O
coronaries	coronary	NNS	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
normal	normal	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
to	to	TO	I-NP	O
55	55	CD	I-NP	O
percent	percent	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
akinesis	akinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
tricuspid	tricuspid	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
regurgitive	regurgitive	JJ	I-NP	O
velocity	velocity	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
2.7	2.7	CD	I-NP	O
meters	meter	NNS	I-NP	O
per	per	IN	B-PP	O
second	second	JJ	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
TSH	TSH	NN	I-NP	O
recently	recently	RB	B-VP	O
checked	check	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Slipper	Slipper	NNP	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
TCH	TCH	NN	B-NP	B-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
present	present	JJ	B-ADJP	O
,	,	,	O	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
worried	worry	VBN	I-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
having	have	VBG	B-VP	O
had	have	VBN	I-VP	O
tachyarrhythmia	tachyarrhythmia	NN	B-NP	O
from	from	IN	B-PP	O
some	some	DT	B-NP	O
other	other	JJ	I-NP	O
source	source	NN	I-NP	O
causing	cause	VBG	B-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Electrophysiology	Electrophysiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
interrogated	interrogate	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pacer	pacer	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
tachyarrhythmias	tachyarrhythmia	NNS	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
TSH	TSH	NN	I-NP	O
panel	panel	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
TSH	TSH	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
T4	T4	NN	B-NP	O
free	free	JJ	I-NP	O
thyroxin	thyroxin	NN	I-NP	O
index	index	NN	I-NP	O
elevated	elevate	VBN	B-VP	O
.	.	.	O	O

An	An	DT	B-NP	O
Endocrinology	Endocrinology	NNP	I-NP	O
consultation	consultation	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
believed	believe	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
thyrotoxicosis	thyrotoxicosis	NN	I-NP	O
was	be	VBD	B-VP	O
amiodarone	amiodarone	NN	B-NP	O
induced	induce	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Tapazole	Tapazole	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
suggested	suggest	VBD	B-VP	O
prednisone	prednisone	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
refuse	refuse	VB	I-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Endocrine	Endocrine	NN	B-NP	O
in	in	IN	B-PP	O
about	about	RB	B-NP	O
four	four	CD	I-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
final	final	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
flash	flash	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
was	be	VBD	B-VP	O
amiodarone	amiodarone	NN	B-NP	O
induced	induced	JJ	I-NP	O
thyrotoxicosis	thyrotoxicosis	NN	I-NP	O
causing	cause	VBG	B-VP	O
increased	increase	VBN	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
to	to	TO	B-PP	O
tachyarrhythmia	tachyarrhythmia	NN	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
pump	pump	NN	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
causing	cause	VBG	B-VP	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
final	final	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
problem	problem	NN	I-NP	O
will	will	MD	B-VP	O
consist	consist	VB	I-VP	O
of	of	IN	B-PP	O
heavy	heavy	JJ	B-NP	O
nodal	nodal	JJ	I-NP	O
blockade	blockade	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
blockaded	blockade	VBN	I-VP	O
with	with	IN	B-PP	O
calcium	calcium	NN	B-NP	O
channel	channel	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Lopressor	Lopressor	NN	B-NP	B-protein
.	.	.	O	O

Pneumonia	Pneumonia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
fully	fully	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

Urinary	Urinary	NNP	B-NP	O
Tract	Tract	NNP	I-NP	O
Infection	Infection	NNP	I-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
lot	lot	NN	I-NP	O
of	of	IN	B-PP	O
uric	uric	JJ	B-NP	O
crystals	crystal	NNS	I-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
Double	Double	NNP	I-NP	O
Strength	Strength	NNP	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
clearly	clearly	RB	B-ADVP	O
severe	severe	JJ	B-NP	O
anxiety	anxiety	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
panic	panic	NN	I-NP	O
attack	attack	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
acutely	acutely	RB	B-ADVP	O
with	with	IN	B-PP	O
Ativan	Ativan	NNP	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
problem	problem	NN	I-NP	O
resolved	resolve	VBD	B-VP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
more	more	RBR	B-ADJP	O
comfortable	comfortable	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Diabetes	Diabetes	NNP	B-NP	O
Mellitus	Mellitus	NNP	I-NP	O
:	:	:	O	O
Glyburide	Glyburide	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
relatively	relatively	RB	B-NP	O
high	high	JJ	I-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
these	these	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
300s	300	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

Edema	Edema	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
clearly	clearly	RB	B-ADVP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
fluid	fluid	JJ	I-NP	O
accumulation	accumulation	NN	I-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
with	with	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
this	this	DT	B-NP	O
and	and	CC	O	O
allow	allow	VB	B-VP	O
outpatient	outpatient	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
this	this	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
INCLUDE	INCLUDE	NN	I-NP	O
:	:	:	O	O
Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Tapazole	Tapazole	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5.0	5.0	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Bactrim	Bactrim	NNP	B-NP	O
Double	Double	NNP	I-NP	O
Strength	Strength	NNP	I-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
times	time	NNS	I-NP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
Prempro	Prempro	NN	B-NP	O
0.625	0.625	CD	I-NP	O
/	/	SYM	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
CD	CD	NNP	B-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

FINAL	FINAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Thyrotoxicosis	Thyrotoxicosis	NN	B-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Provins	Provins	NNP	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
9/18	9/18	CD	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	O	O
30	30	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Orejel	Orejel	NNP	I-NP	O
of	of	IN	B-PP	O
Chia	Chia	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Endocrinology	Endocrinology	NNP	I-NP	O
at	at	IN	B-PP	O
U	U	NNP	B-NP	O
Hay	Hay	NNP	I-NP	O
Rill	Rill	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
7/16	7/16	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MARKUS	MARKUS	NNP	B-NP	O
TRAFICANTE	TRAFICANTE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
LA93	LA93	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
OSVALDO	OSVALDO	NNP	B-NP	O
H.	H.	NNP	I-NP	O
CONDUFF	CONDUFF	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WC6	WC6	NNP	I-NP	O
WP735/7723	WP735/7723	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
64140	64140	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

B8GR7X78AF	B8GR7X78AF	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/10	3/10	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/15	1/15	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

BOYCE	BOYCE	NNP	B-NP	O
F.	F.	NNP	I-NP	O
MARWICK	MARWICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
XU63	XU63	NNP	I-NP	O
,	,	,	O	O
BLOOBY	BLOOBY	NNP	B-NP	O
HONOR	HONOR	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
,	,	,	O	O
Ette	Ette	NNP	B-NP	O
,	,	,	O	O
Utah	Utah	NNP	B-NP	O
08029	08029	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

LENNY	LENNY	NNP	B-NP	O
M.	M.	NNP	I-NP	O
PANNY	PANNY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
XK7	XK7	NNP	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

COLUMBUS	COLUMBUS	NNP	B-NP	O
SHIHADEH	SHIHADEH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
HS1	HS1	NN	I-NP	B-protein

